A detailed history of Nemes Rush Group LLC transactions in Pfizer Inc stock. As of the latest transaction made, Nemes Rush Group LLC holds 141,030 shares of PFE stock, worth $3.91 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
141,030
Previous 117,749 19.77%
Holding current value
$3.91 Million
Previous $3.27 Billion 20.76%
% of portfolio
0.54%
Previous 0.47%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$25.26 - $29.6 $588,078 - $689,117
23,281 Added 19.77%
141,030 $3.95 Billion
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $1.23 Million - $1.42 Million
47,622 Added 67.91%
117,749 $3.27 Billion
Q4 2023

Feb 09, 2024

SELL
$26.13 - $33.94 $90,279 - $117,262
-3,455 Reduced 4.7%
70,127 $2.02 Billion
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $93,638 - $109,454
2,918 Added 4.13%
73,582 $2.44 Billion
Q2 2023

Aug 02, 2023

BUY
$36.12 - $41.79 $2.55 Million - $2.95 Million
70,664 New
70,664 $2.59 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $156B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Nemes Rush Group LLC Portfolio

Follow Nemes Rush Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nemes Rush Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nemes Rush Group LLC with notifications on news.